ARIAD Pharmaceuticals, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ARIAD Pharmaceuticals, Inc.
Gilead looks set to expand its lead position in the triple-negative breast cancer (TNBC) market in Europe with a positive opinion for Trodelvy from the CHMP.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
The latest development over the licensing arrangement for the anticancer drug may deal a further blow to BeiGene’s oncology commercial efforts in China.
Dexcom is making CGM data available through consumer devices starting with Garmin’s smartwatches and bicycle computers.